Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling.
Medicine (Baltimore)
; 99(37): e22194, 2020 Sep 11.
Article
in En
| MEDLINE
| ID: mdl-32925794
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Esophageal Neoplasms
/
Multifunctional Enzymes
/
Aminohydrolases
/
Methylenetetrahydrofolate Dehydrogenase (NADP)
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Medicine (Baltimore)
Year:
2020
Type:
Article